SecBot SecBot
PRESS-RELEASE ·Filed Oct 26, 2026

AKBA

Akebia Therapeutics, Inc.
BULLISH
Impact 6/10
Processed10h 52m ago Wirepress-3388182
Press release · FDA

Price Chart

Loading chart...

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3388182
7 reports for AKBA
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for AKBA — sortable, filterable
TypeNow
Oct 26, 2026
today
Press Release
BULLISH ★ 6/10
—awaiting T+60——
Oct 23, 2026
3d ago
8-K
BEARISH ★ 7/10
$0.5746awaiting T+60—$0.5670 (+1.32%)
Oct 14, 2026
12d ago
8-K
NEUTRAL ★ 3/10
$0.7020awaiting T+60—$0.5670 (−19.23%)
Sep 22, 2026
4w ago
Institutional Cluster
MIXED ★ 3/10
$0.9800awaiting T+60—$0.5670 (−42.14%)
Jun 30, 2026
16w ago
8-K
BULLISH ★ 7/10
$1.14 $0.9326▼ −18.19%▼ −21.76%$0.5670 (−50.26%)
Apr 30, 2026
25w ago
Press Release
NEUTRAL ★ 1/10
$1.40awaiting T+60—$0.5670 (−59.50%)
Feb 26, 2026
34w ago
8-K
BULLISH ★ 7/10
$1.32 $1.02▼ −22.73%▼ −30.48%$0.5670 (−57.05%)
Showing 7 of 7

US Market Status

Market Closed — Opens Wed (13h 16m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 26, 2026

Fresh AKBA Intelligence

Analysis is for subscribers only.

Subscribe for Full Access